Market›Health Care›Health Care Equipment & Supplies›Health Care Supplies
XTANT MED HLDGS INC

XTNT

$0.52Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Supplies$66M
MVM
+$0.0M

Every news event mapped to its market reaction — 103 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-03-01+29.3%legalSEC EDGARXTNT 8-K: 1.01, 2.01, 2.03, 7.01 (SEC Filing)
2022-03-08-23.5%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2024-09-03-19.4%newsSeeking AlphaXtant Medical files to sell 7.81M shares of common stock
2024-09-03-19.4%legalSEC EDGARXTNT 8-K: 8.01 and (SEC Filing)
2023-06-20+19.3%legalSEC EDGARXTNT 8-K: 1.01 and (SEC Filing)
2023-08-01+18.9%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2025-05-13+18.4%earningsSeeking AlphaXtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products
2025-05-13+18.4%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript
2025-04-16+17.5%legalSEC EDGARXTNT 8-K: 1.02, 2.02, 5.01, 7.01, 8.01 (SEC Filing)
2024-05-15-16.9%earningsSeeking AlphaXtant Medical GAAP EPS of -$0.03 misses by $0.02, revenue of $27.9M beats by $2.13M
2024-05-15-16.9%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2024-11-13-16.1%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript
2025-05-12+16.0%newsSeeking AlphaXtant Medical files to sell 73.11M shares of common stock for holders
2025-05-12+16.0%earningsSeeking AlphaXtant Medical GAAP EPS of $0.00 beats by $0.01, revenue of $32.9M beats by $1.68M
2025-05-12+16.0%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2024-04-01-14.6%newsSeeking AlphaXtant Medical files for $150M mixed shelf offering
2024-04-01-14.6%earningsSeeking AlphaXtant Medical Holdings Inc. (XTNT) Q4 2023 Earnings Call Transcript
2024-04-01-14.6%earningsSeeking AlphaXtant Medical GAAP EPS of -$0.03 in-line, revenue of $28.1M beats by $1.55M
2024-04-01-14.6%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-07-03-13.9%legalSEC EDGARXTNT 8-K: 1.01, 2.02, 3.02, 7.01, 8.01 (SEC Filing)
2022-01-03+13.7%legalSEC EDGARXTNT 8-K: 5.02, 7.01 (SEC Filing)
2022-08-31+9.9%legalSEC EDGARXTNT 8-K: 3.02, 5.02, 7.01, 8.01 (SEC Filing)
2024-11-12-9.4%earningsSeeking AlphaXtant Medical GAAP EPS of -$0.04 misses by $0.01, revenue of $27.94M misses by $1.36M
2024-11-12-9.4%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2022-08-24+9.1%legalSEC EDGARXTNT 8-K: 1.01, 3.02, 5.02, 8.01 (SEC Filing)
2024-05-16-8.8%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript
2025-08-12+8.8%earningsSeeking AlphaXtant Medical raises 2025 revenue outlook to $131M–$135M as it divests noncore assets and advances biologics platform
2025-08-12+8.8%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
2025-08-12+8.8%earningsSeeking AlphaXtant Medical GAAP EPS of $0.02 beats by $0.03, revenue of $35.4M beats by $4.05M
2025-08-12+8.8%earningsSeeking AlphaXtant Medical beats top-line and bottom-line estimates; raises FY25 outlook
2025-08-12+8.8%legalSEC EDGARXTNT 8-K: 2.02, 7.01 (SEC Filing)
2023-08-09-7.8%legalSEC EDGARXTNT 8-K: 8.01 (SEC Filing)
2024-08-08-7.4%newsSeeking AlphaXtant Medical to raise $5M through private placement
2024-08-08-7.4%legalSEC EDGARXTNT 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2024-08-08-7.4%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2025-08-08-6.9%legalSEC EDGARXTNT 8-K: 8.01 (SEC Filing)
2025-03-06-6.8%earningsSeeking AlphaXtant Medical GAAP EPS of -$0.02 misses by $0.01, revenue of $31.51M misses by $0.29M
2025-03-06-6.8%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-02-01-6.8%legalSEC EDGARXTNT 8-K: 8.01 (SEC Filing)
2022-10-11+6.5%legalSEC EDGARXTNT 8-K: 3.02, 7.01 (SEC Filing)
2025-03-07-6.2%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript
2022-10-28-6.2%legalSEC EDGARXTNT 8-K: 5.02, 5.07 (SEC Filing)
2021-05-11-6.0%legalSEC EDGARXTNT 8-K: 2.02, 8.01 (SEC Filing)
2025-11-11-5.5%earningsSeeking AlphaXtant Medical reiterates $131M–$135M 2025 revenue guidance as company pursues strategic asset sale and ramps orthobiologics innovation
2025-11-11-5.5%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
2026-03-31-5.5%earningsGuruFocus.comXtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
2026-03-31-5.5%earningsMobyXtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary
2026-03-31-5.5%earningsMarketBeatXtant Medical Q4 Earnings Call Highlights
2026-03-31-5.5%newsPR NewswireXtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-03-31-5.5%earningsSeeking AlphaXtant outlines $95M-$99M 2026 revenue outlook as Companion Spine divestiture and Q-code license revenue roll off
2026-03-31-5.5%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
2026-03-31-5.5%earningsSeeking AlphaXtant Medical beats top-line and bottom-line estimates; gives FY26 outlook
2026-03-31-5.5%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2026-03-31-5.5%earningsStock TitanXtant Medical (NYSE: XTNT) turns profit in 2025, guides 2026 revenue to $95–99M - Stock Titan
2021-11-12-5.3%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2024-03-07+5.0%newsSeeking AlphaXtant Medical increases revolving credit facility to $17M
2024-03-07+5.0%legalSEC EDGARXTNT 8-K: 1.01, 2.03, 7.01 (SEC Filing)
2026-03-02+4.3%newsPR NewswireXtant Medical Finalizes Companion Spine Transactions
2026-03-02+4.3%legalSEC EDGARXTNT 8-K: 8.01 (SEC Filing)
2026-03-02+4.3%newsStock TitanSpine asset sale brings Xtant $21.4M to cut debt, add cash - Stock Titan
2023-11-09-4.1%earningsSeeking AlphaXtant Medical Holdings Inc. (XTNT) Q3 2023 Earnings Call Transcript
2023-11-09-4.1%earningsSeeking AlphaXtant Medical GAAP EPS of $0.07 beats by $0.09, revenue of $25.02M beats by $6.12M
2023-11-09-4.1%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2026-04-13+4.0%expansionPR NewswireXtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
2026-04-13+4.0%legalSEC EDGARXTNT 8-K: 7.01, 8.01 (SEC Filing)
2026-04-13+4.0%M&AStock TitanXtant adds 20-person sales team in HEMOBLAST U.S. deal - Stock Titan
2026-04-13+4.0%M&ATipRanksXtant Medical Expands Portfolio with HEMOBLAST Distribution Deal - TipRanks
2023-05-04+3.9%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-05-04+3.9%legalSEC EDGARXTNT 8-K: 5.02 and (SEC Filing)
2026-04-21+3.6%newsBenzinga12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
2025-07-08-3.5%legalSEC EDGARXTNT 8-K: 1.01, 7.01, 8.01 (SEC Filing)
2023-07-28+3.3%legalSEC EDGARXTNT 8-K: 5.02, 5.03, 5.07 (SEC Filing)
2026-03-25+3.0%newsPR NewswireXtant Medical to Announce Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
2026-03-25+3.0%earningsStock TitanXtant Medical sets March 31 call for Q4 and full-year 2025 results - Stock Titan
2023-03-07-3.0%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-11-20+2.9%executiveSeeking AlphaXtant Medical says chief commercial officer Brandt buys 41.7K shares in co
2025-08-04-2.8%legalSEC EDGARXTNT 8-K: 5.02 and (SEC Filing)
2023-08-10+2.6%legalSEC EDGARXTNT 8-K: 1.01, 2.01, 7.01 (SEC Filing)
2026-04-22-2.5%earningsCổng thông tin điện tử Tỉnh Sơn LaXtant (XTNT) Stock Prediction | Xtant Medical posts 100% EPS surprise, beats loss estimates - Revision Upgrade - Cổng thông tin điện tử Tỉnh Sơn La
2026-04-22-2.5%newsBenzinga12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
2025-04-11+2.5%legalSEC EDGARXTNT 8-K: 1.01 and (SEC Filing)
2026-04-14+2.1%newsMinichartXtant Medical Holdings, Inc. (XTNT) - Minichart
2021-05-06-2.1%legalSEC EDGARXTNT 8-K: 1.01, 1.02, 2.03 (SEC Filing)
2026-01-16+2.1%legalSEC EDGARXTNT 8-K: 8.01 (SEC Filing)
2022-11-03-1.9%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2024-08-10-1.7%earningsSeeking AlphaXtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call Transcript
2026-04-09+1.6%newsPR NewswireXtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial
2026-04-09+1.6%newsStock TitanMontana plans donor memorial as 86% of residents register - Stock Titan
2021-08-05-1.6%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2026-02-25+1.5%newsPR NewswireXtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
2025-12-03+1.2%legalSEC EDGARXTNT 8-K: 2.01, 2.04, 7.01 (SEC Filing)
2022-05-02-1.1%legalSEC EDGARXTNT 8-K: 5.02 and (SEC Filing)
2023-01-09+0.9%legalSEC EDGARXTNT 8-K: 5.02, 7.01 (SEC Filing)
2023-05-18+0.8%legalSEC EDGARXTNT 8-K: 5.02, 7.01 (SEC Filing)
2022-05-05-0.6%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-10-23-0.6%legalSEC EDGARXTNT 8-K: 7.01, 8.01 (SEC Filing)
2025-11-10-0.5%earningsSeeking AlphaXtant Medical GAAP EPS of $0.01 beats by $0.02, revenue of $33.26M beats by $0.56M
2025-11-10-0.5%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2025-11-10-0.5%legalSEC EDGARXTNT 8-K: 5.02, 5.07 (SEC Filing)
2026-04-23-0.4%earningsUBND thành phố Hải PhòngXtant (XTNT) Stock Prediction | Xtant Medical posts 100% EPS surprise, beats loss estimates - Trending Buy Opportunities - UBND thành phố Hải Phòng
2026-04-23-0.4%earningsCổng thông tin điện tử tỉnh Lào CaiXtant (XTNT) Stock: Risks and Growth Potential | Q4 2025: Earnings Beat Estimates - Operating Income - Cổng thông tin điện tử tỉnh Lào Cai
2022-08-04+0.2%legalSEC EDGARXTNT 8-K: 2.02 and (SEC Filing)
2023-07-11-0.2%legalSEC EDGARXTNT 8-K: 1.01 and (SEC Filing)
tickerdossier.comtickerdossier.substack.com